Atlas Trials

Convalescent Plasma for the Treatment of Patients With WNV - a Double- Blind Randomized Controlled Study

Clinical trial NCT06590207 · COMPLETED

Trial details

NCT number
NCT06590207
Sponsor
Sheba Medical Center
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
West Nile Fever With Neurologic Manifestation (Diagnosis)West Nile Fever Without Complications
Start date
2024-07-04
Primary completion
2025-01-31
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.